Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization

Nanoscale Research Letters

Volumn 7, Issue , 2012, Pages 2-32

  Karaman, Didem Sen ^a   Desai, Diti ^a,b   Senthilkumar, Rajendran ^a   Johansson, Emma M ^c   Råtts, Natalie ^a,d   Odén, Magnus ^c   Eriksson, John E ^a   Sahlgren, Cecilia ^a,d   Toivola, Diana M ^a,e   Rosenholm, Jessica M ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b M S UNIVERSITY OF BARODA   (India)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UNIVERSITY OF TURKU   (Finland)

^e Turku Center for Disease Modeling   (Finland)

Author keywords

Cellular internalization; Mesoporous silica nanoparticles; Nanomedicine; Rod shaped particles; Surface charge; Surface functionalization

Indexed keywords

BIODISTRIBUTIONS; CANCER CELL LINES; CELL LINES; CELLULAR INTERNALIZATION; CELLULAR UPTAKE; DOSE CONTROL; DRUG FORMULATIONS; FUNCTIONALIZED; INORGANIC NANOPARTICLE; MESOPOROUS SILICA NANOPARTICLES; MORPHOLOGY EFFECT; NANOCARRIERS; ORGANIC MODIFICATION; PARTICLE MORPHOLOGIES; PARTICLE SHAPE; PASSIVE TARGETING; PHYSICOCHEMICAL PROPERTY; ROD-LIKE PARTICLES; ROD-SHAPED PARTICLES; SPHERICAL MESOPOROUS SILICA; SURFACE FUNCTIONALIZATION;

CELL CULTURE; DRUG DOSAGE; MEDICAL NANOTECHNOLOGY; MORPHOLOGY; NANOPARTICLES; SURFACE CHARGE;

SYNTHESIS (CHEMICAL);

EID: 84863996628     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-7-358     Document Type: Article

References (39)

1. Niemeyer CM: Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science. Angew Chem Int 2001, 40:4128-4158.
2. Mitagotri S: In drug delivery, shape does matter. Pharmaceutical Research 2009, 26(1):232-234.
3. Venkataraman A, Hedrick JL, Ong ZY, Yang C, Rachel Ee PL, Hammond PT, Yang YY: The effects of polymeric nanostructure shape on drug delivery. Adv Drug Delivery Rev 2011, 63:1228-1246.
4. Gratton SEA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM: The effect of particle design on cellular internalization pathways. PNAS 2008, 105(33):11613-11618.
5. Mitragotri S: Designer polymer particles for drug delivery [abstract]. In Tools for ADMET and Pharmaceutical Nanotechnology: September 18-20 2011; Helsinki. 2011. Edited by Helsinki Drug Research 2011. Helsinki: University of Helsinki; 2011.
6. Decuzzi P, Pasqualini R, Arap W, Ferrari M: Intravascular delivery of particulate systems: does geometry really matter? Pharmaceutical Research 2009, 26(1):235-243.
7. Rosenholm JM, Sahlgren C, Lindén M: Towards intelligent, targeted drug delivery systems using mesoporous silica nanoparticles - opportunities & challenges. Nanoscale 2010, 2:1870-1883.
8. Popat A, Hartono SB, Stahr F, Liu J, Qiao SZ, Lu GQ: Mesoporous silica nanoparticles for bioadsorption, enzyme immobilization, and delivery carriers. Nanoscale 2011, 3:2801-2818.
9. Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI: Mesoporous silica nanopartilces in biomedical applications. Chem Soc Rev 2012. doi:10.1039/c1cs15246g.
10. Lee JE, Lee N, Kim T, Kim J, Hyeon T: Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc Chem Res 2011, 44(10):893-902.
11. Rosenholm JM, Mamaeva V, Sahlgren C, Lindén M: Nanoparticles in targeted cancer therapy: mesoprous silica nanopartilces entering preclinical development stage. Nanomedicine 2012, 7:111-120.
12. Huang X, Teng X, Chen D, Tang F, He J: The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 2010, 31:438-448.
13. Meng H, Yang S, Li Z, Xia T, Chen J, Ji Z, Zhang H, Wang X, Lin S, Huang C, Zhou ZH, Zink JI, Nel AE: Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano 2011, 5(6):4434-4447.
14. Huang X, Li L, Liu T, Hao N, Liu H, Chen D, Tang F: The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibilty in vivo. ACS Nano 2011, 5(7):5390-5399.
15. Yu T, Malugin A, Ghandehari H: Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 2011, 5:5717-5728.
16. Trewyn BG, Nieweg JA, Zhao Y, Lin VSY: Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration. Chem Eng J 2008, 137:23-29.
17. He Q, Shi J, Chen F, Zhu M, Zhang L: An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 2010, 31(12):3335-3346.
18. Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, Sahlgren C, Lindén M: Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 2009, 3(1):197-206.
19. Rosenholm JM, Penninkangas A, Lindén M: Amino-functionalization of large-pore mesoscopically ordered silica by a one-step hyperbranching polymerization of a surfacegrown polyethyleneimine. Chem Commun 2006, 37:3909-3911.
20. Rosenholm JM, Lindén M: Wet-chemical analysis of surface concentration of accessible groups on different amino-functionalized mesoporous SBA-15 silicas. Chem Mater 2007, 19:5023-5034.
21. Rosenholm JM, Duchanoy A, Lindén M: Hyperbranching surface polymerization as a tool for preferential functionalization of the outer surface of mesoporous silica. Chem Mater 2008, 20:1126-1133.
22. Johansson EM, Ballem MA, Córdoba JM, Odén M: Rapid synthesis of SBA-15 rods with variable lengths, widths, and tunable large pores. Langmuir 2011, 27:4994-4999.
23. Bergman L, Rosenholm JM, Öst AB, Duchanoy A, Kankaanpää P, Heino J, Lindén M: On the complexity of electrostatic suspension stabilization of functionalized silicananoparticles for biotargeting and -imaging applications. J Nanomaterials 2008. doi:10.1155/2008/712514.
24. Zintchenko A, Philipp A, Dehshahri A, Wagner E: Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjugate Chem 2008, 19:1448-1455.
25. Johansson EM, Córdoca JM, Odén M: Effect of heptane addition on pore size and particle morphology of mesoporous silica SBA-15. Microporous Mesoporous Mater 2010, 133:66-74.
26. Li M, Wang N, Liang Y, Zhang J: Preparation of monodisperse short rod-like mesoporous silica. Chinese J Mat Res 2006, 20(2):181-185.
27. Selvan ST, Aldeyab SS, Zaidi JSM, Arivuoli D, Ariga K, Mori T, Vinu A: Preparation and characterization of highly ordered mesoporous SiC nanoparticles with rod shaped morphology and tunable pore diameters. J Mater Chem 2011, 21:8792-8799.
28. Cook A, Le A: The effect of solvent and pH on the fluorescence excitation and emission spectra of solutions containing fluorescein. J Phys Chem Lab 2006, 10:44-49.
29. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995, 92(16):7297-7301.
30. Sahlin S, Hed J, Rundquist I: Differentation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay. J Immunoll Methods 1983, 60:115-124.
31. Rosenholm JM, Peuhu E, Eriksson JE, Sahlgren C, Lindén M: Targeted intracellular delivery and release of hydrophobic agents using mesoporous hybrid silica nanoparticles as drug carrier systems. Nano Letters 2009, 9:3308-3311.
32. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Kandapallil B, Bawendi MG, Frangioni JV: Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
33. Verma A, Stellacci F: Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6:12-21.
34. Champion JA, Mitragotri S: Shape induced inhibition of phagocytosis of polymer particles. Pharmaceutical Research 2009, 26(1):244-249.
35. Liu TL, Li LL, Teng X, Huang XL, Liu HY, Chen D, Ren J, He JQ, Tang FQ: Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 2011, 32:1657-1668.
36. Lin YS, Haynes CL: Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. JACS 2010, 132(13):4834-4842.
37. Rosenholm JM, Sahlgren C, Lindén M: Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. Current Drug Targets 2011, 12(8):1166-1186.
38. Rosenholm JM, Zhang J, Sun W, Gu H: Large-pore mesoporous silica-coated magnetite core-shell nanocomposites and their relevance for biomedical applications. Microporous Mesoporous Materials 2011, 145(1-3):14-20.
39. Kolhar P, Doshi N, Mitragotri S: Polymer nanoneedle-mediated intracellular drug delivery. Small 2011, 7(14):2094-2100.